Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus
- 77 Downloads
Evidences indicate that abnormal lipid metabolism and lipid peroxidation can affect the progression of complications in systemic lupus erythematosus (SLE) patients. Apolipoprotein E (ApoE) and paraoxonase-1 (PON1) play important role in lipid metabolism and protection of lipid peroxidation. The polymorphisms of ApoE and paraoxonase (PON1) L55M (Met < Leu) allele genes lead to disorders in lipid metabolism and are related to atherosclerosis. This study is the first investigation to examine the possible association between ApoE and PON1-L55M polymorphisms and correlation with serum arylesterase (ARE) activities of PON, levels of malondialdehyde (MDA), neopterin, and lipid lipoprotein in SLE patients from Iranian western population. The present case-control study consisted of 107 SLE patients and 101 gender- and age-matched, unrelated, healthy controls from Iran’s western population. The ApoE and PON1-L55M genotypes were identified using PCR-RFLP method. The serum level of MDA, neopterin, lipid levels, and ARE activity were determined by HPLC, commercial kits, and spectrophotometry, respectively. Our results showed that ApoE ε4 and PON1-55M alleles act synergistically to increase the risk of SLE by 1.47 times (p = 0.038). We found that the frequency of ApoE Ɛ3/Ɛ4 genotype was higher in SLE patients (11.2%) compared with control subjects (5%), although the difference was not significant (p = 0.087). This study for the first time not only demonstrates that ApoE Ɛ4 and PON-55M alleles synergistically increase the risk of SLE but also reveals that serum levels of MDA, neopterin, and LDL-C are high in SLE patients. This information may be in value for evaluating SLE progression and in the elucidation of the mechanisms of the disease pathogenesis.
KeywordsApolipoprotein E genotypes Arylesterase activity of paraoxonase Malondialdehyde Neopterin Paraoxonase (PON1)-55 polymorphism Systemic lupus erythematosus
Systemic lupus erythematosus
Reactive oxygen species
Coronary artery disease
Low-density lipoprotein receptor
This work was performed in partial fulfillment of requirements for a M.Sc by degree in Clinical Biochemistry, Kermanshah University of Medical Sciences, Kermanshah, Iran (Ali Miri). All authors contributed equally to this study.
Source of Funding
This study was funded by Kermanshah University of Medical Sciences, Kermanshah, Iran, Grant No. 90324.
Compliance with ethical standards
- 3.Bertsia G, Cervera R, Boumpas DT (2012) Systemic lupus erythematosus: pathogenesis and clinical features. In: EULAR textbook on rheumatic diseases. European League Against Rheumatism, Geneva, pp 476–505Google Scholar
- 6.Repetto M, Boveris A, Semprine J (2012) Lipid peroxidation: chemical mechanism, biological implications and analytical determination. INTECH Open Access Publisher, TehranGoogle Scholar
- 8.Bahrehmand F, Vaisi-Rayagani A, Rahimi Z, Ahmadi R, Kiani A, Tavilani H, Vaisi-Raygani HP (2014) Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report. Lupus 23:263–272CrossRefPubMedGoogle Scholar
- 18.Bahrehmand F, Vaisi-Rayagani A, Rahimi Z, Tavilani H, Navabi S, Shakiba E, Hassanzadeh N, Pourmotabbed T (2012) Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients. Lupus 21:616–624CrossRefPubMedGoogle Scholar
- 25.Ibrahim AA, El-Lebedy D, Ashmawy I, Hady MA (2017) Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt. Clin Rheumatol 36(6):1305–1310Google Scholar
- 28.Pavlova R, Mehrabian S, Petrova M, Skelina S, Mihova K, Jordanova A, Mitev V, Traykov L (2014) Cognitive, neuropsychiatric, and motor features associated with apolipoprotein E Ɛ4 allele in a sample of bulgarian patients with late-onset Parkinson’s disease. Am J Alzheimer’s Dis Other Demen 29(7):614–619CrossRefGoogle Scholar
- 32.Gonzàlez M, Ribalta J, Vives G, Iftimie S, Ferré R, Plana N, Guardiola M, Dallinga-Thie G, Masana L, Castro A (2010) Nuclear magnetic resonance lipoprotein subclasses and the ApoE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus. J Rheumatol 37(11):2259–2267CrossRefPubMedGoogle Scholar
- 38.Al Harthi F, Huraib GB, Zouman A, Arfin M, Tariq M, Al-Asmari A (2014) Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis. Dis Markers 2014:239645Google Scholar